Mellen Center
Welcome,         Profile    Billing    Logout  
 0 Trials 
2 Trials

   

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Bermel, Robert
NCT05663853: An Observational Biomarker Study in Multiple Sclerosis (MS) Patients

Completed
N/A
137
US
LAPIX Therapeutics Inc.
Multiple Sclerosis, Relapsing-Remitting, Multiple Sclerosis, Primary Progressive, Multiple Sclerosis, Secondary Progressive
04/24
04/24
Drenkhan, Emmy
NCT05663853: An Observational Biomarker Study in Multiple Sclerosis (MS) Patients

Completed
N/A
137
US
LAPIX Therapeutics Inc.
Multiple Sclerosis, Relapsing-Remitting, Multiple Sclerosis, Primary Progressive, Multiple Sclerosis, Secondary Progressive
04/24
04/24

Download Options